Literature DB >> 10233930

Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus.

L A Ball1, C R Pringle, B Flanagan, V P Perepelitsa, G W Wertz.   

Abstract

The nonsegmented negative-strand RNA viruses (order Mononegavirales) include many important human pathogens. The order of their genes, which is highly conserved, is the major determinant of the relative levels of gene expression, since genes that are close to the single promoter site at the 3' end of the viral genome are transcribed at higher levels than those that occupy more distal positions. We manipulated an infectious cDNA clone of the prototypic vesicular stomatitis virus (VSV) to rearrange three of the five viral genes, using an approach which left the viral nucleotide sequence otherwise unaltered. The central three genes in the gene order, which encode the phosphoprotein P, the matrix protein M, and the glycoprotein G, were rearranged into all six possible orders. Viable viruses were recovered from each of the rearranged cDNAs. The recovered viruses were examined for their levels of gene expression, growth potential in cell culture, and virulence in mice. Gene rearrangement changed the expression levels of the encoded proteins in concordance with their distance from the 3' promoter. Some of the viruses with rearranged genomes replicated as well or slightly better than wild-type virus in cultured cells, while others showed decreased replication. All of the viruses were lethal for mice, although the time to symptoms and death following inoculation varied. These data show that despite the highly conserved gene order of the Mononegavirales, gene rearrangement is not lethal or necessarily even detrimental to the virus. These findings suggest that the conservation of the gene order observed among the Mononegavirales may result from immobilization of the ancestral gene order due to the lack of a mechanism for homologous recombination in this group of viruses. As a consequence, gene rearrangement should be irreversible and provide an approach for constructing viruses with novel phenotypes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233930      PMCID: PMC112512     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus.

Authors:  S U Emerson; Y Yu
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

2.  Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus.

Authors:  G W Wertz; V P Perepelitsa; L A Ball
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

3.  Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus.

Authors:  A R Carroll; R R Wagner
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

4.  Interferon production in mice by vesicular stomatitis virus.

Authors:  J S Youngner; G Wertz
Journal:  J Virol       Date:  1968-11       Impact factor: 5.103

5.  Homotypic and heterotypic exclusion of vesicular stomatitis virus replication by high levels of recombinant polymerase protein L.

Authors:  E Meier; G G Harmison; M Schubert
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Role of matrix protein in cytopathogenesis of vesicular stomatitis virus.

Authors:  D Blondel; G G Harmison; M Schubert
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

7.  Pathogenicity and immunogenicity for mice of temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  R R Wagner
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

8.  Characterization and mapping of RNase III cleavage sites in VSV genome RNA.

Authors:  G W Wertz; N Davis
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

9.  Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo.

Authors:  B L Black; D S Lyles
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

10.  Infectious defective interfering particles of VSV from transcripts of a cDNA clone.

Authors:  A K Pattnaik; L A Ball; A W LeGrone; G W Wertz
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

View more
  62 in total

1.  Computation, prediction, and experimental tests of fitness for bacteriophage T7 mutants with permuted genomes.

Authors:  D Endy; L You; J Yin; I J Molineux
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders.

Authors:  H Badrane; N Tordo
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization.

Authors:  Cornelis A M de Haan; Haukeline Volders; Cheri A Koetzner; Paul S Masters; Peter J M Rottier
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response.

Authors:  E B Flanagan; L A Ball; G W Wertz
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Recombinant rinderpest vaccines expressing membrane-anchored proteins as genetic markers: evidence of exclusion of marker protein from the virus envelope.

Authors:  E P Walsh; M D Baron; L F Rennie; P Monaghan; J Anderson; T Barrett
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression.

Authors:  Gail W Wertz; Robin Moudy; L Andrew Ball
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Fitness analyses of vesicular stomatitis strains with rearranged genomes reveal replicative disadvantages.

Authors:  Isabel S Novella; L Andrew Ball; Gail W Wertz
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Level of gene expression is a major determinant of protein evolution in the viral order Mononegavirales.

Authors:  Israel Pagán; Edward C Holmes; Etienne Simon-Loriere
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

Review 9.  Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.

Authors:  David K Clarke; R Michael Hendry; Vidisha Singh; John K Rose; Stephen J Seligman; Bettina Klug; Sonali Kochhar; Lisa Marie Mac; Baevin Carbery; Robert T Chen
Journal:  Vaccine       Date:  2016-07-06       Impact factor: 3.641

10.  Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting.

Authors:  Elizabeth J Kelly; Rebecca Nace; Glen N Barber; Stephen J Russell
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.